Form 4: Alignment Healthcare CEO John Kao Sells Shares to Cover Tax Obligations

Alignment Healthcare's CEO, John Kao, sold shares on March 18th and 19th, 2025, to cover tax withholding obligations related to vested stock.

Summary

• John Kao, CEO of Alignment Healthcare, sold shares of common stock on March 18th and 19th, 2025.
• These sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units and the grant of immediately vested common stock.
• On March 18, 2025, 27,535 shares were sold at a weighted-average price of $16.8906.
• On March 19, 2025, two transactions occurred: 21,846 shares were sold at a weighted-average price of $16.088, and 12,255 shares were sold at a weighted-average price of $16.9588.
• Following these transactions, Mr. Kao directly owns 4,957,616 shares and indirectly owns 2,093,100 shares through the JEK Trust dated February 8, 2021, where he serves as trustee.

Sentiment

Score: 5

Explanation: The document reflects routine transactions to cover tax obligations, which is neither particularly positive nor negative. It's a neutral event.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on the stock price due to the increased selling volume.
• However, since the sales are for tax obligations, they are unlikely to reflect a change in the CEO's long-term outlook for the company.

Key Dates

Keywords

Alignment Healthcare, ALHC, John Kao, stock sale, Form 4, tax obligations, restricted stock units, JEK Trust, insider trading